Chembio diagnostics receives $4 million hiv test purchase order supported by the global fund

Hauppauge, n.y., july 22, 2021 (globe newswire) -- chembio diagnostics, inc. (nasdaq: cemi), a leading point-of-care diagnostic company focused on infectious diseases, announced its receipt today of a $4 million purchase order from the partnership for supply chain management (pfscm), supported by the global fund, for the purchase of chembio's hiv 1/2 stat-pak assay for shipment to ethiopia into early 2022. chembio's delivery of the full number of tests covered by the purchase order may be affected by limitations of chembio's supply chain, staffing, and liquidity, and other matters outside chembio's control.
CEMI Ratings Summary
CEMI Quant Ranking